AMRN FY 2012 Earnings — Amarin Corporation plc Revenue & Financial Results | Market Cap Arena

AMRNAmarin Corporation plc

$333M

FY 2012 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

$0

Operating Income

-$117M

Net Income

-$179M

EPS (Diluted)

$-24.80

Cash Flow

Operating Cash Flow

-$122M

Free Cash Flow

-$135M

Stock-Based Comp.

$18M

Balance Sheet

Total Assets

$311M

Total Liabilities

$315M

Stockholders' Equity

-$4M

Cash & Equivalents

$260M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	$0	$0	—
Operating Income	-$117M	-$44M	-163.2%
Net Income	-$179M	-$69M	-158.1%